Wells Fargo & Company Bio Rad Laboratories, Inc. Transaction History

Wells Fargo & Company

  • $434 Billion
  • Q3 2024

A detailed history of Wells Fargo & Company transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 42,765 shares of BIO stock, worth $14 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
42,765
Previous 44,017 2.84%
Holding current value
$14 Million
Previous $12 Million 19.03%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$263.97 - $344.64 $330,490 - $431,489
-1,252 Reduced 2.84%
42,765 $14.3 Million
Q2 2024

Aug 13, 2024
BUY
$268.26 - $339.48 $520,424 - $658,591
1,940 Added 4.61%
44,017 $12 Million
Q1 2024

May 10, 2024
BUY
$304.11 - $351.99 $1.89 Million - $2.19 Million
6,218 Added 17.34%
42,077 $14.6 Million
Q4 2023

Feb 09, 2024
SELL
$269.37 - $365.04 $1.37 Million - $1.86 Million
-5,087 Reduced 12.42%
35,859 $11.6 Million
Q3 2023

Nov 13, 2023
BUY
$350.25 - $422.63 $4.17 Million - $5.03 Million
11,910 Added 41.02%
40,946 $14.7 Million
Q2 2023

Aug 15, 2023
SELL
$359.49 - $486.4 $185,496 - $250,982
-516 Reduced 1.75%
29,036 $11 Million
Q1 2023

May 12, 2023
BUY
$418.69 - $503.0 $1.88 Million - $2.26 Million
4,494 Added 17.93%
29,552 $14.2 Million
Q4 2022

Feb 13, 2023
BUY
$351.71 - $456.01 $363,316 - $471,058
1,033 Added 4.3%
25,058 $10.5 Million
Q3 2022

Nov 14, 2022
SELL
$412.59 - $563.26 $417,953 - $570,582
-1,013 Reduced 4.05%
24,025 $10 Million
Q2 2022

Aug 12, 2022
SELL
$463.67 - $597.16 $14.7 Million - $18.9 Million
-31,677 Reduced 55.85%
25,038 $12.4 Million
Q1 2022

May 16, 2022
BUY
$524.57 - $735.42 $2.78 Million - $3.9 Million
5,302 Added 10.31%
56,715 $31.9 Million
Q4 2021

Feb 14, 2022
SELL
$708.84 - $794.68 $217 Million - $244 Million
-306,737 Reduced 85.64%
51,413 $38.8 Million
Q3 2021

Nov 15, 2021
BUY
$657.71 - $825.77 $8.54 Million - $10.7 Million
12,986 Added 3.76%
358,150 $267 Million
Q2 2021

Aug 16, 2021
SELL
$576.64 - $649.04 $3.21 Million - $3.61 Million
-5,567 Reduced 1.59%
345,164 $222 Million
Q1 2021

May 13, 2021
BUY
$547.01 - $662.35 $5.88 Million - $7.12 Million
10,751 Added 3.16%
350,731 $200 Million
Q4 2020

Feb 09, 2021
SELL
$510.68 - $643.45 $37.8 Million - $47.7 Million
-74,096 Reduced 17.89%
339,980 $198 Million
Q3 2020

Nov 05, 2020
SELL
$454.43 - $535.6 $52.2 Million - $61.5 Million
-114,911 Reduced 21.72%
414,076 $213 Million
Q2 2020

Aug 13, 2020
BUY
$334.87 - $493.06 $6.91 Million - $10.2 Million
20,621 Added 4.06%
528,987 $239 Million
Q1 2020

May 14, 2020
BUY
$320.01 - $409.07 $163 Million - $208 Million
508,366 New
508,366 $178 Million

Others Institutions Holding BIO

# of Institutions
466
Shares Held
18.7M
Call Options Held
19.5K
Put Options Held
13.9K
View Full List

About BIO-RAD LABORATORIES, INC.

BIO Quotes by TradingView
  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.06B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email